Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Can MEDP's Record Q2 Bookings Build a Stronger Growth Path for 2027?
Can MEDP's Record Q2 Bookings Build a Stronger Growth Path for 2027?

Medpace Holdings, Inc. MEDP regained commercial momentum in the second quarter of 2026 as record awards and a higher book-to-bill ratio reversed the weaker first-quarter trend.

The central issue is

Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock
Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock

Regeneron (REGN) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its

Earnings Estimates Rising for RPC (RES): Will It Gain?
Earnings Estimates Rising for RPC (RES): Will It Gain?

RPC (RES) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its

Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?
Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?

Launched on 04/24/2012, the VanEck Morningstar Wide Moat ETF (MOAT) is a smart beta exchange traded fund offering broad exposure to the Style Box - Large Cap Blend category of the market.

What Are

Is Schwab Fundamental U.S. Small Company ETF (FNDA) a Strong ETF Right Now?
Is Schwab Fundamental U.S. Small Company ETF (FNDA) a Strong ETF Right Now?

A smart beta exchange traded fund, the Schwab Fundamental U.S. Small Company ETF (FNDA) debuted on 08/13/2013, and offers broad exposure to the Style Box - Small Cap Value category of the market.

AEVA Q2 Earnings Beat on Service Growth and Gross Profit
AEVA Q2 Earnings Beat on Service Growth and Gross Profit

Aeva Technologies, Inc. AEVA reported an adjusted loss of 41 cents per share for the second quarter of 2026, narrower than the Zacks Consensus Estimate and the year-ago loss of 44 cents.

Revenues

NWL vs. CLX: Which Stock Is the Better Value Option?
NWL vs. CLX: Which Stock Is the Better Value Option?

Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of Newell Brands (NWL) and Clorox (CLX). But which of these two companies is the best option

BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down
BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.23 in the third quarter of fiscal 2026, up 4.9% year over year. The figure topped the

Atmos Energy Q3 Earnings Beat Estimates, Revenues Increase Y/Y
Atmos Energy Q3 Earnings Beat Estimates, Revenues Increase Y/Y

Atmos Energy ATO reported fiscal third-quarter 2026 earnings of $1.43 per share, beating the Zacks Consensus Estimate of $1.34 by 6.7%. The bottom line improved 23.3% from $1.16 in the year-ago

Quantinuum's First Earnings After its IPO: Buy or Sell QNT Stock?: https://staticx-tuner.zacks.com/images/articles/main/30/172914.webp
Quantinuum's First Earnings After its IPO: Buy or Sell QNT Stock?

Quantinuum Inc. QNT is scheduled to release second-quarter 2026 results after the closing bell on Aug. 11. The earnings report will cover the three months ended June 30 and will mark Quantinuum’s

Should Vanguard Growth Index Fund ETF Shares (VUG) Be on Your Investing Radar?
Should Vanguard Growth Index Fund ETF Shares (VUG) Be on Your Investing Radar?

If you're interested in broad exposure to the Large Cap Growth segment of the US equity market, look no further than the Vanguard Growth Index Fund ETF Shares (VUG), a passively managed exchange

Should Vanguard Small-Cap Value Index Fund ETF Shares (VBR) Be on Your Investing Radar?
Should Vanguard Small-Cap Value Index Fund ETF Shares (VBR) Be on Your Investing Radar?

Looking for broad exposure to the Small Cap Value segment of the US equity market? You should consider the Vanguard Small-Cap Value Index Fund ETF Shares (VBR), a passively managed exchange traded

Should State Street SPDR Portfolio S&P 500 Growth ETF (SPYG) Be on Your Investing Radar?
Should State Street SPDR Portfolio S&P 500 Growth ETF (SPYG) Be on Your Investing Radar?

If you're interested in broad exposure to the Large Cap Growth segment of the US equity market, look no further than the State Street SPDR Portfolio S&P 500 Growth ETF (SPYG), a passively managed

Should Invesco S&P SmallCap 600 Revenue ETF (RWJ) Be on Your Investing Radar?
Should Invesco S&P SmallCap 600 Revenue ETF (RWJ) Be on Your Investing Radar?

If you're interested in broad exposure to the Small Cap Blend segment of the US equity market, look no further than the Invesco S&P SmallCap 600 Revenue ETF (RWJ), a passively managed exchange

Is American Century U.S. Quality Growth ETF (QGRO) a Strong ETF Right Now?
Is American Century U.S. Quality Growth ETF (QGRO) a Strong ETF Right Now?

Launched on 09/10/2018, the American Century U.S. Quality Growth ETF (QGRO) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Growth category of the market.

Pattern Group (PTRN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Pattern Group (PTRN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Shares of Pattern Group (PTRN) have been struggling lately and have lost 7.8% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the

Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake
Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake

Insmed INSM reported an adjusted loss of 52 cents per share in the second quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of 69 cents.

The adjusted figure excluded a non-cash

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Supernus Pharmaceuticals (SUPN) and Teva Pharmaceutical Industries Ltd. (TEVA). But which of these two

Earnings Estimates Moving Higher for Sunoco LP (SUN): Time to Buy?
Earnings Estimates Moving Higher for Sunoco LP (SUN): Time to Buy?

Sunoco LP (SUN) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum
DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum

Denali Therapeutics DNLI reported a second-quarter 2026 loss of 68 cents per share, narrower than the Zacks Consensus Estimate of a loss of 73 cents. The company incurred a loss of 72 cents in the